Privia Health Group, Inc.
PRVA Nasdaq· Services-Health Services
Last close · Oct 26, 2026
$22.16
KIRA · Stoqly’s AI analyst, in plain words
- Privia Health Group, Inc. had $2.1B of revenue in fiscal 2025, up 22.3% on the year before. Over five years, revenue changed +21.0% a year on average.
- Its operating margin was 1.6%, up 0.6 pts: of every 100 in sales, about 2 is left after running the business.
- Privia Health Group, Inc. made $22.9M of net profit in fiscal 2025. From fiscal 2019 to 2025, diluted EPS grew 12.2% a year.
Market cap
$2.9B
P/E
100.7x
Revenue
$2.1B
Net income
$22.9M
Free cash flow
—
Operating margin
1.6%
Privia Health Group, Inc. in 30 seconds · fiscal 2025
Are sales growing?
+22.3%
Yes. Sales grew 22.3% last year.
Does it make a profit?
1.1%
A little. It keeps 1.1% of every sale as profit.
How healthy are the accounts?
5 / 7
Mixed. It passes 5 of 7 health tests.
How is the share priced?
100.7x
One share costs 100.7 times its yearly profit per share.
What Privia Health Group, Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 27, 2026
- Legal name
- Privia Health Group, Inc.
- CIK
- 0001759655
Privia Health Group, Inc. · PRVA
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $966M | $1.4B | $1.7B | $1.7B | $2.1B |
| Revenue growth | 18.3% | 40.4% | 22.2% | 4.7% | 22.3% |
| Net interest income | −$1.1M | $0.5M | $8.4M | — | — |
| Operating margin | −22.5% | −1.4% | 1.2% | 1.0% | 1.6% |
| Net income | −$188M | −$8.6M | $23.1M | $14.4M | $22.9M |
| Net margin | −19.5% | −0.6% | 1.4% | 0.8% | 1.1% |
| Diluted EPS | −$1.83 | −$0.08 | $0.19 | $0.11 | $0.18 |
| Cash | |||||
| Cash from operations | $55.1M | $47.2M | $80.8M | $109M | $163M |
| Capital expenditure | $0.5M | $0.1M | $0.1M | — | — |
| Free cash flow | $54.5M | $47.1M | $80.7M | — | — |
| FCF margin | 5.6% | 3.5% | 4.9% | — | — |
| Share count change | 7.3% | 7.5% | 12.6% | 0.7% | 2.6% |
| Debt and strength | |||||
| Cash and short-term investments | $321M | $348M | $390M | $491M | $480M |
| Shareholders' equity | $427M | $499M | $561M | $635M | $737M |
| Current ratio | 2.3x | 2.1x | 1.8x | 1.9x | 1.6x |
| Interest coverage | −197.7x | −38.2x | — | — | — |
| Returns and quality | |||||
| Return on equity | −65.6% | −1.9% | 4.4% | 2.4% | 3.3% |
| Return on tangible equity | −78.7% | −2.7% | 7.3% | 3.7% | 7.4% |
| Piotroski F-score | 3 | 4 | 4 | 4 | 5 |
| Altman Z'' | 1.2 | 3.2 | 3.1 | 3.3 | 2.8 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$22.2M
4 insiders
Of sales under plans
87%
$19.4M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Privia Health Group, Inc. · PRVA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $22.16 a share, the company is worth $2.9B: 100.7 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001759655). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.